Non-small cell lung cancer (NSCLC) patients with chemotherapy will be enrolled. Patients will be thoroughly informed about all aspects of the study activity schedule and all regulatory requirements that must be satisfied for informed consent. Only patients who give consent to participate in this study and meet all other inclusion and exclusion criteria will be eligible to enroll into this study. ICD-10 fatigue criteria, Brief Fatigue Inventory-Taiwan Form (BFI-T), the visual analog scale (VAS) for appetite and Functional Assessment of Cancer Therapy-General quality of life questionnaire (FACT-G7) will be used to evaluate patients' fatigue and quality of life. Patients who enrolled in this observational study will complete the evaluation and questionnaire of fatigue and quality of life according to clinical schedule. The first survey (baseline) will be collected after enrollment, the further surveys will be completed every three chemotherapy cycles following subject's chemotherapy schedule and after finish the whole course of chemotherapy. Subject demographic and disease-related information and routine laboratory data will also be collected from medical record for analysis.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who signed the informed consent form.
Aged 20 years and older.
Patients who have been given a diagnosis of stage II-IV NSCLC cancer.
Patients who are under/ or scheduled for chemotherapy treatment.
Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2.
Patients who are able to complete QoL questionnaires.
You may not be if
Patients have enrolled or have not yet completed other investigational drug trials within 30 days before screening.